Kai Xu
Internal Medicine Residency · UMass Chan Medical School
Credentials: · ·
History
- 2025–Present
- 2018–2021
Cert Leadership Essentials University of Pennsylvania Perelman School of Medicine
Research
Grants
- 2024–2029
Development of Broadly Neutralizing Nanobodies for Advancing AIDS Therapy
National Institute of Allergy and Infectious Diseases · R01
PI · $2.4M · Wistar Institute
- 2023–2028
Structure, Function, and Antigenicity of Emerging Henipavirus Surface Glycoproteins
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $2.4M · Ohio State University
- 2024–2027
Paramyxoviridae and Bunyavirales Vaccines and Antibodies Center (PABVAX)
National Institute of Allergy and Infectious Diseases · U19
Project lead · $4.6M · University of Texas Med Br Galveston
- 2023–2026
Targeting Glycoprotein (G) Domain-III for Pan-Lyssavirus Nanobody Therapeutics
National Institute of Allergy and Infectious Diseases · UH2
Contact PI · $423.2K · University of Texas Hlth Sci Ctr Houston